Overview:
Canine arthritis is a major disease seen in middle-aged to older dogs. Cartilage deficits, tick-borne disease, fungus, bacteria spread through the blood supply, infection in the joint, stresses on the joint, disruption of cartilage, synovial membranes, bone, and ligaments that support a joint, poor nutrition, injuries such as anterior cruciate ligament, trauma after a car accident, and penetration of joint by a sharp object or bite are some of the most common causes of canine arthritis. Symptoms may include reluctance to jumping, nervous or aggressive behavior, gain or loss of weight, licking of joints, pain, swelling, muscle atrophy, urinating indoors, difficulty in rising from rest, slow gait, lameness and stiffness, and lethargy and tendency to sleep more.
Request Here For PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2433
Drivers:
Increasing adoption of companion animals, such as dog, increasing awareness among people about veterinary care, and rise in number of approvals for veterinary medicines are expected to boost the growth of the global canine arthritis market during the forecast period. For instance, in March 2016, Aratana Therapeutics, Inc. announced that the Food and Drug Administration’s Center for Veterinary Medicine (CVM) approved GALLIPRANT (tablets) for the control of pain and inflammation associated with osteoarthritis in dogs.
Moreover, favorable initiatives to support pet care are expected to augment growth of the global canine arthritis treatment market. For instance, in January 2019, International Boarding & Pet Services Association (IBPSA) announced the appointment of 3 new members to serve on its advisory board to bring an additional and invaluable experiences of pet care business to IBPSA.
Restraints:
Side effects associated with canine arthritis treatment are expected to hamper the growth of the global canine arthritis treatment market.
Regional Insights:
Among regions, North America is expected to witness robust growth in the market due to the increasing adoption of pets, increase in product launches and the presence of major players in the region. For instance, in July 2018, CBD DOG Health announced the launch of a new collections. The new collection contains a full-spectrum hemp oil with multiple cannabinoids including CBD, CBG, CBN, and CBDA, which all work in concert to reduce anxiety, slow tumor growth, reduce bacteria, treat hot spots and skin problems, reduce pain, and provide a host of other positive benefits for pets, treating canine skin problems, pain, anxiety, cancers, and dozens of other common ailments
Get PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/2433
Moreover, in 2017-2018, according to the National Pet Owners Survey conducted by Ipsos, Inc., pet ownership in the U.S. households stands at 68% as compared to 48% in 2016.
Competitive landscape:
Major players active in the global canine arthritis market are Elanco (Eli Lilly and Company), Zoetis Inc., Boehringer Ingelheim, Bayer, Vetoquinol S.A., Aratana Therapeutics, VetStem Biopharma, Norbrook Laboratories Limited, CBD DOG Health, and Dechra Pharmaceuticals Plc., among others.
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Canine Arthritis Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Canine Arthritis Industry Impact
Chapter 2 Global Canine Arthritis Competition by Types, Applications, and Top Regions and Countries
2.1 Global Canine Arthritis (Volume and Value) by Type
2.3 Global Canine Arthritis (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Canine Arthritis Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Canine Arthritis Market Analysis
Chapter 6 East Asia Canine Arthritis Market Analysis
Chapter 7 Europe Canine Arthritis Market Analysis
Chapter 8 South Asia Canine Arthritis Market Analysis
Chapter 9 Southeast Asia Canine Arthritis Market Analysis
Chapter 10 Middle East Canine Arthritis Market Analysis
Chapter 11 Africa Canine Arthritis Market Analysis
Chapter 12 Oceania Canine Arthritis Market Analysis
Chapter 13 South America Canine Arthritis Market Analysis
Chapter 14 Company Profiles and Key Figures in Canine Arthritis Business
Chapter 15 Global Canine Arthritis Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Buy This Report with Flat USD 2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2433
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837